Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies

Rose P. Webster, Leslie Myatt

Resultado de la investigación: Review articlerevisión exhaustiva

10 Citas (Scopus)


Preeclampsia, a disease of pregnancy, is a multisystem disorder associated with elevated maternal blood pressure, proteinurea, oedema, and fetal abnormalities. It is a major cause of mortality, morbidity, perinatal death, and premature delivery. Despite active research in the past decade, there is yet no definitive cure for preeclampsia. The disease has been treated symptomatically with antihypertensives, antieclamptics, bed rest, and a whole gamut of isolated therapies. In an attempt to understand the molecular basis of this disease and many other fatal diseases including cancer and heart disease, the scientific community has been turning to understanding the genome and more lately the "proteome". Proteomics enables researchers to identify all proteins expressed in a cell or organ and detect any PTM in the protein expression patterns. Deciphering the placental proteome and studying the differences in protein expression patterns in the normal as against the preeclamptic proteome might possibly in future lead to early detection and therapeutic targeting of preeclampsia.

Idioma originalEnglish (US)
Páginas (desde-hasta)1147-1155
Número de páginas9
PublicaciónProteomics - Clinical Applications
EstadoPublished - sept 2007
Publicado de forma externa

ASJC Scopus subject areas

  • Clinical Biochemistry


Profundice en los temas de investigación de 'Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies'. En conjunto forman una huella única.

Citar esto